Guenther, Lyn, et al. “Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial”. Acta Dermato-Venereologica, vol. 100, no. 1, Jan. 2020, pp. 1-9, doi:10.2340/00015555-3353.